Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Emerging Drugs
List of Issues
Volume 25, Issue 3

Expert Opinion on Emerging Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Emerging Drugs, Volume 25, Issue 3 (2020)

Browse this journal

Latest articles
Current issue
List of issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Emerging Drugs, Volume 25, Issue 3 (2020)

See all volumes and issues

Vol 29, 2024 Vol 28, 2023 Vol 27, 2022 Vol 26, 2021 Volume 25, 2020 Vol 24, 2019 Vol 23, 2018 Vol 22, 2017 Vol 21, 2016 Vol 20, 2015 Vol 19, 2014 Vol 18, 2013 Vol 17, 2012 Vol 16, 2011 Vol 15, 2010 Vol 14, 2009 Vol 13, 2008 Vol 12, 2007 Vol 11, 2006 Vol 10, 2005 Vol 9, 2004 Vol 8, 2003 Vol 7, 2002 Vol 6, 2001 Vol 6, 2001 Vol 5, 2000 Vol 4, 1999 Vol 3, 1998 Vol 2, 1997

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Emerging drugs for the treatment of hidradenitis suppurativa

Alecia S Folkes, Faris Z Hawatmeh, Alan Wong & Francisco A Kerdel

Pages: 201-211

Published online: 22 Jul 2020

AbstractforEmerging drugs for the treatment of hidradenitis suppurativa | Full Text | References | PDF (303.1 KB) | EPUB

451 Views
8 CrossRef citations
0Altmetric

Clinical trials and novel therapeutics in dermatomyositis

Tanya Chandra & Rohit Aggarwal

Pages: 213-228

Published online: 10 Jul 2020

AbstractforClinical trials and novel therapeutics in dermatomyositis | Full Text | References | PDF (702.7 KB) | EPUB

808 Views
9 CrossRef citations
0Altmetric

Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer

Toshio Fujino, Kenichi Suda & Tetsuya Mitsudomi

Pages: 229-249

Published online: 16 Jul 2020

1401 Views
21 CrossRef citations
0Altmetric

Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists

Raj A. Shah, Naim Alkhouri & Kris V Kowdley

Pages: 251-260

Published online: 12 Aug 2020

AbstractforEmerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists | Full Text | References | PDF (768.6 KB) | EPUB

404 Views
10 CrossRef citations
0Altmetric

Emerging drugs for the treatment of diabetic retinopathy

Elio Striglia, Andrea Caccioppo, Niccolò Castellino, Michele Reibaldi & Massimo Porta

Pages: 261-271

Published online: 05 Aug 2020

AbstractforEmerging drugs for the treatment of diabetic retinopathy | Full Text | References | PDF (317.6 KB) | EPUB

653 Views
14 CrossRef citations
0Altmetric

Emerging drugs for the treatment of chronic pruritic diseases

Kayla Fourzali, Rachel Shireen Golpanian & Gil Yosipovitch

Pages: 273-284

Published online: 12 Aug 2020

AbstractforEmerging drugs for the treatment of chronic pruritic diseases | Full Text | References | PDF (962 KB) | EPUB

307 Views
7 CrossRef citations
0Altmetric

Emerging drugs for the treatment of neuromyelitis optica

Ankelien Duchow, Claudia Chien, Friedemann Paul & Judith Bellmann-Strobl

Pages: 285-297

Published online: 25 Aug 2020

AbstractforEmerging drugs for the treatment of neuromyelitis optica | Full Text | References | PDF (591.1 KB) | EPUB

541 Views
14 CrossRef citations
0Altmetric

Emerging drugs for the treatment of light chain amyloidosis

Rajshekhar Chakraborty & Suzanne Lentzsch

Pages: 299-317

Published online: 24 Aug 2020

AbstractforEmerging drugs for the treatment of light chain amyloidosis | Full Text | References | PDF (708.6 KB) | EPUB

839 Views
8 CrossRef citations
0Altmetric

Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs

Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza

Pages: 319-335

Published online: 20 Aug 2020

AbstractforAnti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs | Full Text | References | PDF (487.8 KB) | EPUB

1562 Views
48 CrossRef citations
0Altmetric

Emerging therapeutics for the management of COVID 19

Sujit Kumar Debnath, Rohit Srivastava & Abdelwahab Omri

Pages: 337-351

Published online: 08 Sep 2020

AbstractforEmerging therapeutics for the management of COVID 19 | Full Text | References | PDF (1.4 MB) | EPUB

1260 Views
6 CrossRef citations
0Altmetric

Mini-Review

Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors

Haritha G. Reddy, Angel Qin & Gregory P. Kalemkerian

Pages: 353-366

Published online: 04 Aug 2020

AbstractforEmerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors | Full Text | References | PDF (2.7 MB) | EPUB

407 Views
4 CrossRef citations
0Altmetric

Emerging drugs for treatment of focal segmental glomerulosclerosis

Howard Trachtman

Pages: 367-375

Published online: 12 Aug 2020

AbstractforEmerging drugs for treatment of focal segmental glomerulosclerosis | Full Text | References | PDF (290.7 KB) | EPUB

358 Views
9 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update

Joshua Winograd et al.

Review Article | Published online: 6 Jun 2024

Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease

Hui Jue Wang et al.

Review Article | Published online: 1 Jun 2024

Emerging drugs for the treatment of short bowel syndrome

Tristan Frau et al.

Review Article | Published online: 23 May 2024

Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder

Elliot Hampsey et al.

Review Article | Published online: 8 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Emerging Drugs (Vol.25, Iss.3, 2020)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?